Literature DB >> 20466275

Herpes viruses in transplant recipients: HSV, VZV, human herpes viruses, and EBV.

Kevin Shiley1, Emily Blumberg.   

Abstract

The herpes viruses are responsible for a wide range of diseases in patients following transplant, resulting from direct viral effects and indirect effects, including tumor promotion. Effective treatments and prophylaxis exist for the neurotropic herpes viruses HSV-1, HSV-2, varicella zoster virus, and possibly HHV-6. Antivirals seem to be less effective at prevention of the tumor-promoting effects of Epstein-Barr virus and HHV-8. Reduction in immunosuppression is the cornerstone to treatment of many diseases associated with herpes virus infections. Copyright (c) 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20466275     DOI： 10.1016/j.idc.2010.01.003

Source DB:  PubMed          Journal:  Infect Dis Clin North Am        ISSN： 0891-5520            Impact factor:   5.982


  10 in total

1.  Myalgic encephalomyelitis/chronic fatigue syndrome and gulf war illness patients exhibit increased humoral responses to the herpesviruses-encoded dUTPase: Implications in disease pathophysiology.

Authors:  Peter Halpin; Marshall Vance Williams; Nancy G Klimas; Mary Ann Fletcher; Zachary Barnes; Maria Eugenia Ariza
Journal:  J Med Virol       Date:  2017-04-26       Impact factor: 2.327

2.  Human CD4+ T cell response to human herpesvirus 6.

Authors:  Maria-D Nastke; Aniuska Becerra; Liusong Yin; Omar Dominguez-Amorocho; Laura Gibson; Lawrence J Stern; J Mauricio Calvo-Calle
Journal:  J Virol       Date:  2012-02-22       Impact factor: 5.103

3.  Global Mapping of O-Glycosylation of Varicella Zoster Virus, Human Cytomegalovirus, and Epstein-Barr Virus.

Authors:  Ieva Bagdonaite; Rickard Nordén; Hiren J Joshi; Sarah L King; Sergey Y Vakhrushev; Sigvard Olofsson; Hans H Wandall
Journal:  J Biol Chem       Date:  2016-04-15       Impact factor: 5.157

4.  Evaluation of a Next-Generation Sequencing Metagenomics Assay to Detect and Quantify DNA Viruses in Plasma from Transplant Recipients.

Authors:  Soya S Sam; Ralph Rogers; Fizza S Gillani; Gregory J Tsongalis; Colleen S Kraft; Angela M Caliendo
Journal:  J Mol Diagn       Date:  2021-03-09       Impact factor: 5.568

5.  Herpes simplex virus type-1 (HSV-1) entry into human mesenchymal stem cells is heavily dependent on heparan sulfate.

Authors:  Samiksha Choudhary; Maribel Marquez; Frances Alencastro; Frank Spors; Yuanxiang Zhao; Vaibhav Tiwari
Journal:  J Biomed Biotechnol       Date:  2011-06-21

Review 6.  Herpesviruses dUTPases: A New Family of Pathogen-Associated Molecular Pattern (PAMP) Proteins with Implications for Human Disease.

Authors:  Marshall V Williams; Brandon Cox; Maria Eugenia Ariza
Journal:  Pathogens       Date:  2016-12-28

7.  Functionality testing of stem cell grafts to predict infectious complications after allogeneic hematopoietic stem cell transplantation.

Authors:  J Nilsson; I Granrot; J Mattsson; B Omazic; M Uhlin; S Thunberg
Journal:  Vox Sang       Date:  2017-05-02       Impact factor: 2.144

8.  Global aspects of viral glycosylation.

Authors:  Ieva Bagdonaite; Hans H Wandall
Journal:  Glycobiology       Date:  2018-07-01       Impact factor: 4.313

9.  Association between Antiviral Prophylaxis and Cytomegalovirus and Epstein-Barr Virus DNAemia in Pediatric Recipients of Allogeneic Hematopoietic Stem Cell Transplant.

Authors:  Ndeye Soukeyna Diop; Pascal Roland Enok Bonong; Chantal Buteau; Michel Duval; Jacques Lacroix; Louise Laporte; Marisa Tucci; Nancy Robitaille; Philip C Spinella; Geoffrey Cuvelier; Suzanne M Vercauteren; Victor Lewis; Caroline Alfieri; Helen Trottier
Journal:  Vaccines (Basel)       Date:  2021-06-07

10.  Clinical course and therapeutic approach to varicella zoster virus infection in children with rheumatic autoimmune diseases under immunosuppression.

Authors:  Raphael Leuvenink; Florence Aeschlimann; Walter Baer; Gerald Berthet; Elvira Cannizzaro; Michael Hofer; Daniela Kaiser; Silke Schroeder; Ulrich Heininger; Andreas Woerner
Journal:  Pediatr Rheumatol Online J       Date:  2016-06-02       Impact factor: 3.054
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.